Direxion Daily Healthcare Bull 3X Shares
CURE

$125.42

1.64%

Market Cap: 201M

0

Funds holding %

of 6,702 funds

–

Analysts bullish %

–

News positive %

Fund manager confidence

Based on 2024 Q1 SEC filings by fund managers ($100M+ AUM)

100% more first-time investments, than exits

New positions opened: 4 | Existing positions closed: 2

39% more call options, than puts

Call options by funds: $4.3M | Put options by funds: $3.1M

23% more capital invested

Capital invested by funds: $21.6M [Q4 2023] → $26.6M (+$5M) [Q1 2024]

11% more funds holding

Funds holding: 19 [Q4 2023] → 21 (+2) [Q1 2024]

0.7% more ownership

Funds ownership: 11.8% [Q4 2023] → 12.5% (+0.7%) [Q1 2024]

0% more funds holding in top 10

Funds holding in top 10: 1 [Q4 2023] → 1 (+0) [Q1 2024]

50% less repeat investments, than reductions

Existing positions increased: 4 | Existing positions reduced: 8

See Fund Rankings

Research analyst outlook

We haven’t received any recent analyst ratings for CURE.

See Analyst Rankings

Financial journalist opinion

Investors Business Daily

Are Health Care Stocks Setting Up A 'CURE' For Your Portfolio?

With support at its 21-day line, this health care ETF gave us a scratch trade in February but may be setting up again.

Are Health Care Stocks Setting Up A 'CURE' For Your Portfolio?

Healthcare Showing That Big Tech Isn't the Only Bull in Town

While capital markets are seemingly fixated on the astounding returns of big tech and the growth prospects of artificial intelligence (AI), the sector isn't the only bull in town. The healthcare sector is also outperforming and shouldn't be overlooked by long- and short-term investors.

Healthcare Showing That Big Tech Isn't the Only Bull in Town

JD Henning Cautious About 2024, An Unusual Year For Market Considerations

JD Henning discusses his approach to the market and emphasizes the importance of timing and using momentum gauges to avoid major market downturns. Investing vs trading portfolios.

JD Henning Cautious About 2024, An Unusual Year For Market Considerations

AI Adoption in Healthcare Spells Opportunity in 2 ETFs

Traders eyeing potential plays in the new year may want to look at the healthcare sector given its growing adoption of artificial intelligence (AI). Technological advancement in healthcare should spell opportunities in the Direxion Daily Healthcare Bull 3X ETF (CURE) and the Direxion Daily Robotics, Artificial Intelligence & Automation Index Bull 2X ETF (UBOT).

AI Adoption in Healthcare Spells Opportunity in 2 ETFs

Top Performing Leveraged/Inverse ETFs: 11/26/2023

These were last week's top performing leveraged and inverse ETFs. Note that because of leverage, these kinds of funds can move quickly.

Top Performing Leveraged/Inverse ETFs: 11/26/2023

Zacks Investment Research

Best Inverse/Leveraged ETFs of Last Week

Wall Street experienced a four-week winning streak last week.

Best Inverse/Leveraged ETFs of Last Week

Healthcare Dashboard, And The Side Effects Of CURE

Pharmaceuticals/biotechnology and life science tools are close to their historical baseline in value and quality. Healthcare equipment is the most overvalued subsector. Ten healthcare stocks cheaper than their peers in November.

Healthcare Dashboard, And The Side Effects Of CURE

See News Rankings